aas

Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025

June 14, 2025 10:48 ET  | Source: Celldex Therapeutics, Inc. 77% of patients (150 mg Q4W) treated with barzolvolimab who…

3 weeks ago

Reebok and Global Music Icon Anuel AA Reunite for Second Capsule Collection

Drop 2, “Sport Love”, delivers bold footwear and apparel inspired by Anuel AA’s signature style – fusing chrome details, heritage…

3 weeks ago